CD4+ T-cell–directed antibody responses are maintained in patients with psoriasis receiving alefacept: results of a randomized study (Q52004908)
Jump to navigation
Jump to search
scientific article published on November 1, 2003
Language | Label | Description | Also known as |
---|---|---|---|
English | CD4+ T-cell–directed antibody responses are maintained in patients with psoriasis receiving alefacept: results of a randomized study |
scientific article published on November 1, 2003 |
Statements
CD4+ T-cell–directed antibody responses are maintained in patients with psoriasis receiving alefacept: results of a randomized study (English)
CD4+ T-cell-directed antibody responses are maintained in patients with psoriasis receiving alefacept: results of a randomized study (English)
Hans D Ochs
1 reference
Thomas B. Casale
Ellen Frankel
1 reference
Bernard Goffe
1 reference
Nicholas Lowe
1 reference
Ken Washenik
1 reference
Alice B. Gottlieb
Janet L. Roberts
Akshay K. Vaishnaw
1 November 2003
1 reference
49
1 reference
5
1 reference
816-825
1 reference
Identifiers
1 reference